“Kyphosis Market Research Report - Forecast to 2025” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2025.
Kyphosis is a spinal disorder in which an excessive outward curve of the spine results in a weak spine, causing abnormal rounding of the upper back. Kyphosis does not have any characteristic symptom other than a curved/hunched back. However, in certain cases, the disease is reported to cause back pain, tenderness in the spine, and tiredness. If the disease remains unchecked, it can cause severe pain (untreatable by medication) and breathing difficulties. Thus, right and timely diagnosis is crucial.
Osteoporosis (porous bone) is amongst the major causes of kyphosis. The prevalence of osteoporosis is increasing. It has been reported that approximately 10 million people in the Americas suffer from kyphosis. Such a high prevalence of the disease is estimated to increase the kyphosis patient pool, thus increasing the number of patients seeking treatment. Moreover, factors such as the prevalence of kyphosis, rising healthcare expenditure, and increasing R&D in the market by key players is estimated to drive the market growth. In recent years, Conclusively, Kyphosis Market is expected to grow at a healthy CAGR of 5.8% during the forecast period.
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/1760
Segmentation
The Global Kyphosis Market has been segmented into type, diagnostic test &treatment, and end user.
The market, on the basis of type, has been segmented into postural kyphosis, Scheuermann's kyphosis, and congenital kyphosis.
The market, by diagnostic test & treatment, has been segmented into diagnostic test and treatment. The diagnostic test segment has been segmented into imaging, biopsy, and others. The imaging segment has been divided into X-ray, MRI scan, and CT scan. The treatment segment has been segmented into medications, surgery, and bracing. The medication section has been further sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), and others. The nonsteroidal anti-inflammatory drugs (NSAIDs) has been sub-segmented into aspirin, ibuprofen, and naproxen. The surgery segment is sub-segmented into spinal fusion and osteotomy.
The market, by end-user, has been segmented into hospitals & clinics, diagnostic centers, and academic & research organizations.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The American kyphosis market has been segmented into North America and South America. North American is estimated to lead the market in 2018.
Europe led the market in 2018, followed by the Americas. Based on region, the European kyphosis market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as France, Germany, the UK, Italy, Spain, and the rest of Western Europe.
The Kyphosis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Kyphosis market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, B. Braun Melsungen AG, Integra LifeSciences, Integra Lifesciences Holdings Corp, Johnson and Johnson (DePuy Synthes), Medtronic Plc., MicroPort Scientific Corporation, Nuvasive Inc., NuVasive, Inc., Orthofix Holdings, Inc., Perrigo Company, Stryker Corporation, Teva Pharmaceuticals USA, Inc., Zimmer Biomet Holdings. Inc., and others are some of the Key Players in the Global Kyphosis Market.
Access Report Details @ https://www.marketresearchfuture.com/reports/kyphosis-market-1760
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment